• AsclepiX Therapeutics Raises $5M in New Funding firstwordpharma
    November 14, 2018
    BALTIMORE--(BUSINESS WIRE)-- AsclepiX Therapeutics, Inc., a biopharmaceutical company focused on developing vital new therapies based on a novel peptide platform
PharmaSources Customer Service